Cancel
Known information
- Served as Chief People Officer at Spark Therapeutics, Inc. (Roche Holdings AG)
- Spent 10 years at Shire plc (now Takeda) in various leadership roles within the human resources function
- Held roles in human resources with Franklin Templeton Investments, Applied Biosystems, and Goldman Sachs
- Serves as a member of the Board of Advisors of Life Science Cares Philadelphia
- Is on the External Advisory Board of the Drexel University Solution’s Institute
- Serves as an advisor on the Philadelphia Chamber of Commerce’s Cell & Gene Therapy and Connected Health Initiative committee
- Was named a 'Woman of Distinction' by the Philadelphia Business Journal in 2020
- Holds an M.B.A from Rutgers University School of Business
- Holds a B.A. in psychology from Pennsylvania State University
About Nabriva Therapeutics
Nabriva Therapeutics is a commercial-stage biopharmaceutical company specializing in the development of anti-infective agents for serious infections, with key products including XENLETA® and CONTEPO™.
Report inaccurate information
